Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 12:22 PM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Stock Picks » Strong Buy: VRNA =MC $57 M-- Cash $51 M --COPD Phase 2b data this month



Reply
 
Thread Tools Search this Thread
Old 12-04-2019, 09:37 AM   Nav to Top  #1
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 282
Favorites: Aapl celg onxx
Rep Power: 111
Reputation: 36
Biohero is on a distinguished road
Default VRNA =MC $57 M-- Cash $51 M --COPD Phase 2b data this month

Market-cap $57 M --Cash $51 M --Shares Out 13.17 M --Great Pipeline -- Strong Insider & Institutional Ownership -- Phase 2b readout of the COPD trial is imminent (during this Q) ,positive results could push this extreme low float stock closer or even above $10 . Unsidocvered and brutally undepriced Stock with massive upside Potential here .GL



Verona Pharma (VRNA)

Market-Cap $57 M
Cash $51 M
Price $3.90

Shares Out 13.17 M


"We are very pleased that our four-week Phase 2b dose-ranging clinical trial with nebulized ensifentrine is progressing according to plan and that we have completed enrollment of over 400 symptomatic patients with moderate to severe COPD. We anticipate completing this study around the end of 2019."


Presentation (from late November)
https://investors.veronapharma.com/s...3-1efe276fbffb


Verona Pharma has compound with 'massive potential to impact lives of COPD and asthma patients'...02.12.2019
https://www.biotech-capital.com/comp...s--908274.html


Insider Buying
https://www.lse.co.uk/DirectorsDeals...=Verona-Pharma


Top Shareholders :

Vivo Capital, LLC ...1.5M
OrbiMed ...1.3M
New Enterprise ...1.2M
Abingworth ...901.9K
VenBio Partners LLC ...875.0K
Novo Holdings A/S ...740.7K
Andera Partners ...720.9K
Aisling Capital ...443.6K
Tekla Capital ...275.0K
Arctic Fund ...120.4K

Biohero is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: TNXP (MC $32M) (Cash $34M) O/S 7.5 M / Phase 3 Data in 1H 2018 =More than just cheap Biohero US Stock Picks 6 01-23-2018 05:48 AM
Strong Buy: ACRX (MC $97 M) Cash $72 M / FDA Decision on Oct 12 / P3 results this month Biohero US Stock Picks 2 07-17-2017 09:32 AM
Strong Buy: ACRX (Mcap $54 M) 3x PRODUCTS IN PHASE 3 // RESULTS THIS MONTH =500% Potential !!! Biohero US Stock Picks 0 11-11-2012 05:47 PM
Strong Buy: Cipher Pharma - PartnerDeal & Phase 3 data this Q (Mcap 31M) biotechmaster Canadian Stock Picks 1 05-27-2011 09:12 AM
Strong Buy: CLSN// Phase 3 interim data this Q = Multibagger Potential biotechmaster US Stock Picks 1 05-04-2011 10:52 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On